US high court rules against Amgen in class action
WASHINGTON Feb 27 (Reuters) - The U.S. Supreme Court made it easier on Wednesday to bring class action lawsuits, breaking a line of rulings that had made it more difficult to sue corporate defendants collectively and perhaps obtain greater recoveries.
The case against Amgen Inc concerned what kind of evidence must be presented before companies may be the subject of class action lawsuits.
By 6-3, the court allowed a suit against Amgen to go forward in which the Connecticut Retirement Plans and Trust Funds accuses the biotechnology company of fraudulently inflating its stock price.
- 'Weird Al' Yankovic still trying to wrap head around No. 1 album
- French warplanes search Mali desert for crashed Air Algerie plane |
- Wreckage of Air Algerie plane carrying 116 people found in Mali |
- Shelling of Gaza school kills at least 15; toll nears 800 |
- World's oldest joke traced back to 1900 BC